Anti-thymocyte globulin, cyclosporin A and granulocyte colony-stimulating factor for severe aplastic anaemia complicating paediatric liver transplantation

Eur J Pediatr. 1998 Feb;157(2):107-8. doi: 10.1007/s004310050779.

Abstract

We describe a sustained trilineage haematopoietic response to intensified immunosuppressive therapy with anti-thymocyte globulin, cyclosporin A and recombinant human granulocyte colony-stimulating factor in a 4-year-old girl, who developed severe aplastic anaemia after orthotopic liver transplantation for fulminant liver failure induced by non A-E hepatitis. The outcome was successful and allows the following.

Conclusion: Intense immunosuppression in combination with haemopoetic growth factors and antimicrobial prophylaxis should be considered as first line therapy in severe aplastic anaemia after orthotopic liver trans-plantation.

Publication types

  • Case Reports

MeSH terms

  • Anemia, Aplastic / etiology
  • Anemia, Aplastic / immunology
  • Anemia, Aplastic / therapy*
  • Antilymphocyte Serum / therapeutic use*
  • Child, Preschool
  • Cyclosporine / therapeutic use*
  • Female
  • Granulocyte Colony-Stimulating Factor / therapeutic use*
  • Hepatic Encephalopathy / virology
  • Hepatitis, Viral, Human / complications
  • Humans
  • Immunocompromised Host
  • Immunosuppressive Agents / therapeutic use*
  • Liver Transplantation / adverse effects*
  • Liver Transplantation / immunology
  • T-Lymphocytes / immunology*

Substances

  • Antilymphocyte Serum
  • Immunosuppressive Agents
  • Granulocyte Colony-Stimulating Factor
  • Cyclosporine